NEW YORK (GenomeWeb News) – DiscoveryBioMed today said that it has inked a service contract with Lifeline Cell Technology to conduct primary human cell bioassay testing for the subsidiary of International Stem Cell Corp.

The contract partners DBM's expertise in assay development with Lifeline's expertise in producing optimized human adult and stem cell products, said Lifeline CEO Jeffrey Janus.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.